ABOUT

In-House Impact: Life Sciences Summit 2024

The life sciences industry underwent a turbulent 2023, with many companies experiencing challenges with raising funds, the window for IPOs tenuous, and companies reporting numerous layoffs. As a result, the life sciences industry was driven to explore creative strategies to reduce expenses to keep their businesses afloat, and in-house teams had to take a more commercially driven mindset to overcome continued budgeting pressures.

Dedicated to empowering legal teams with actionable solutions to enhance commercial success, we have meticulously gathered top in-house professionals from across the life sciences sector. Together, we explore case studies on leveraging AI and cutting-edge legal technologies to streamline operations, navigate strategic opportunities in financing and M&As, and establish innovative compliance protocols in response to evolving risks.

Join your peers to:

L

everage insights gained from Disc Medicine, Beckman Coulter, American Regent, and Alexion to delve into the mindset of your Executive Leaders, understanding what keeps them up at night by analyzing strategic thinking processes and decision-making approaches to be a commercial asset

E

xamine the practical impact of AI integration within your organization by exploring the laws and regulations of AI to safeguard against risk, with AbbVie

G

rapple with the debate over whether the IRA is a bottleneck or blown out of proportion by analyzing theoretical versus actual risk with Immatics and Aveo Oncology

A

nalyze best practices to ingrain compliance across the whole organization by brainstorming collaborative techniques, technology integrations, and training frameworks with Synolgic, Bridge Biosciences, Vivex, and Assertio Therapeutics

L

everage first-hand insights from BMS and Alexion to ensure a smooth M&A transition by understanding the anticipated pain points experienced by each party, thereby mitigating risk and endorsing business continuity.